A Randomized Controlled Trial of Robotic Support for Enhanced Later Life (RoSELL)
RoSELL
The Impact of Socially Supportive Robotic Intervention on Loneliness, Depression, Self-agency and Well-being in Long-term Care Residents: A Three-Arm Randomized Controlled Trial
2 other identifiers
interventional
90
1 country
1
Brief Summary
The purpose of this study is to compare the efficacy of a personalized, co-designed robot interaction against a standardized, fixed robot interaction for reducing loneliness, depression, as well as improving self-agency and quality of life in older adults. This is a three-arm randomized controlled trial. The study will be conducted at a community center in Fuzhou, China, with 100 participants aged 65+ recruited from the facility. The participants will be randomly assigned to one of three conditions: (1) Co-designed robot (CL) group receiving a personalized robot interaction with a structured co-design ceremony; (2) Standard robot (SL) group interacting with an identical robot without personalization features; or (3) An attention-controlled usual care (CU) group. The intervention comprises 16 sessions (two weekly 20-minute sessions over eight weeks). The primary outcomes are loneliness and depressive symptoms. Secondary outcomes include general self-efficacy, quality of life, as well as staff and participants' perceptions of the robot. Mechanism measures (i.e., engagement, self-disclosure) and manipulation checks (e.g., perceived personal role) will be employed to elucidate the underlying theoretical pathways. Data will be collected at baseline (T0), after the initial 2-week co-design period (T1), post-intervention (T2, Week 8), and at 1-month (T3) and 3-month (T4) follow-ups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 6, 2025
CompletedFirst Submitted
Initial submission to the registry
July 21, 2025
CompletedFirst Posted
Study publicly available on registry
August 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedNovember 19, 2025
November 1, 2025
11 months
July 21, 2025
November 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Loneliness
Measure the loneliness of participants at baseline before the intervention (T0), at the end of Week 2 (T1) following the initial interaction period, at the end of Week 8 (T2) upon completion of the core intervention phase, and at Week 12 (T3) and Week 24 (T4) to assess the sustained effects of the intervention.
From enrollment to the end of treatment at 24 weeks
Depression
Depressive Symptoms will be assessed using the Chinese version of the 15-item Geriatric Depression Scale (GDS-15) at baseline before the intervention (T0), at the end of Week 2 (T1) following the initial interaction period, at the end of Week 8 (T2) upon completion of the core intervention phase, and at Week 12 (T3) and Week 24 (T4).
From enrollment to the end of treatment at 24 weeks.
Secondary Outcomes (2)
Self-Efficacy
From enrollment to the end of treatment at 24 weeks
Quality of life and Wellbeing
From enrollment to the end of treatment at 24 weeks
Other Outcomes (2)
Interaction engagement
From enrollment to the end of treatment at 8 weeks
Self-disclosure
From enrollment to the end of treatment at 8 weeks.
Study Arms (3)
Co-designed robot group
EXPERIMENTALThis intervention arm involves a proactive companion robot delivered over 16 sessions, with a core emphasis on structured personalization to foster attachment. Sessions 1-2 (Personalization Ritual): A healthcare professional facilitates a structured, four-phase co-design ceremony. Sessions 3-16 (Autonomous Interaction): The co-designed robot is placed in the participant's room for autonomous interaction. It uses the personalized settings and exhibits default affectionate behaviors (e.g., approaching, responding to touch). To reinforce the bond, the healthcare professional uses scripted phrases attributing agency and memory to the robot (e.g., "\[Robot's Name\] remembers you"). Participants are encouraged to add one new "memory" per session for the robot to "store."
Standard Robot Group
EXPERIMENTALThis arm involves the same robot for an equivalent duration and number of sessions as the co-design intervention arm, but without the personalization ritual or anthropomorphic framing. Sessions 1-2 (Standardized Introduction): A healthcare professional introduces the same robot, demonstrating its three core, pre-programmed functionalities. The robot has a generic, fixed configuration with identical, pre-set eye color and voice pitch for all participants in this arm. Sessions 3-16 (Neutral, Autonomous Interaction): The standard robot is placed in the participant's room for autonomous interaction. The key differentiator is the deliberately neutral and non-anthropomorphic framing by the healthcare professional
Control
NO INTERVENTIONAll groups will receive the usual community center services. The study district offers standard community-based programming, including group exercises, social events, and recreational activities, all of which are accessible to all residents. Participation is voluntary. To control for attention bias, healthcare professionals will conduct weekly 20-minute individual visits with participants in this group, totaling 16 sessions over the 4-week intervention period.
Interventions
This arm utilizes the LOVOT robot within a structured protocol designed to foster a unique personal attachment through a co-design ceremony and anthropomorphic framing. Personalization Ritual (Sessions 1-2): A healthcare professional facilitates a multi-phase personalization ceremony. Autonomous Interaction (Sessions 3-16): The personalized LOVOT is placed in the participant's room. The robot consistently uses the participant-chosen voice and eye settings.
This arm uses the identical LOVOT robot for an equivalent duration but deliberately excludes personalization and anthropomorphic framing to isolate the effect of generic robot companionship. Standardized Introduction (Sessions 1-2): A healthcare professional introduces the LOVOT robot with a fixed, generic configuration. Neutral Autonomous Interaction (Sessions 3-16): The standard LOVOT is placed in the participant's room. The robot operates with its default outgoing personality and identical sensors (thermal camera, touch, distance) for safe, autonomous movement and recharging.
Eligibility Criteria
You may qualify if:
- The participants were not eligible if they were: (1) already engaged in other socially assistive robot programs, (2) diagnosed with severe psychiatric problems, (3) bed-bound, or (4) living in an area with no Internet coverage.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Jiao Tong University
Shanghai, 200240, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
July 21, 2025
First Posted
August 3, 2025
Study Start
May 6, 2025
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
For protecting user privacy